Related Experiment Video
Updated: Aug 17, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Replacement of the essential penicillin-binding protein 5 by high-molecular mass PBPs may explain
S al-Obeid1, D Billot-Klein, J van Heijenoort
1Laboratoire de Microbiologie Médicale, Université Paris VI, France.
Abstract:
The mechanism of synergy between vancomycin and penicillin, as well as other beta-lactam antibiotics, was examined in a penicillin-resistant E. faecium (D366) expressing an inducible low-level resistance to vancomycin. It was demonstrated that penicillin per se was not able to reduce the inducible expression of the 39.5-kDa protein (VANB) or the carboxypeptidase activity which are involved in the mechanism of vancomycin resistance of this strain. Assays of competition between 3H-benzylpenicillin and diverse beta-lactam antibiotics suggested as the most likely explanation of the synergy that, once vancomycin resistance has been induced, the high-molecular mass penicillin-binding proteins (PBPs), and possibly PBP1 in particular, which have a high affinity for beta-lactam antibiotics, take over the role of the low-affinity PBP5 which is, in the non-induced strain, responsible for beta-lactam resistance.
Insights
Penicillin and vancomycin synergy in resistant E. faecium occurs because high-affinity penicillin-binding proteins (PBPs) compensate for reduced PBP5 function after vancomycin resistance is induced.
Area of Science:
- Microbiology
- Antibiotic Resistance
- Biochemistry
Background:
- Penicillin-resistant Enterococcus faecium (E. faecium) poses a significant clinical challenge.
- Vancomycin resistance in E. faecium is often mediated by inducible resistance mechanisms.
- Understanding antibiotic synergy is crucial for developing effective treatment strategies.
Purpose of the Study:
- To elucidate the mechanism of synergy between vancomycin and penicillin in a vancomycin-resistant E. faecium strain.
- To investigate the role of penicillin-binding proteins (PBPs) in this synergistic interaction.
Main Methods:
- Utilized a penicillin-resistant E. faecium strain (D366) with inducible vancomycin resistance.
- Assessed the effect of penicillin on the expression of vancomycin resistance determinants (VANB protein and carboxypeptidase activity).
- Performed competition assays with radiolabeled penicillin and various beta-lactam antibiotics to study PBP binding affinities.
Main Results:
- Penicillin alone did not reduce the inducible expression of the VANB protein or associated carboxypeptidase activity.
- Synergy is explained by the shift in function to high-molecular mass PBPs (potentially PBP1) with high beta-lactam affinity.
- These high-affinity PBPs assume the role of the low-affinity PBP5, which confers resistance in the non-induced state.
Conclusions:
- The synergy between vancomycin and penicillin in this E. faecium strain is not due to reduced vancomycin resistance gene expression.
- The mechanism involves a functional compensation by high-affinity PBPs once vancomycin resistance is induced.
- This highlights the complex interplay of PBPs in antibiotic resistance and synergy.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Development of Antibiotic Resistance
Production of Antibiotics
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance

